Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Agung Podomoro Land Tbk (APLN) vs Merck Tbk. (MERK) Price & Performance

Agung Podomoro Land TbkTrade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Agung Podomoro Land Tbk vs Merck Tbk. — how do they compare? Agung Podomoro Land Tbk trades at Rp127 (market cap 2.84T, 12.31M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Agung Podomoro Land Tbk is the larger of the two by market cap, and Agung Podomoro Land Tbk is more actively traded (12.31M versus 29.1K). Which is the better fit depends on your goals.

APLNMERK
Market Cap
2.84T1.75T
Volume
12.31M29.1K
Lot
123.14K291
Turnover
1.53B113.37M
Average Price
124.473,895.98
Value
1.53B113.37M
Indicative Equilibrium Price
1273,890
Indicative Equilibrium Volume
3.39K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

APLN
View details
MERK
View details

About Agung Podomoro Land Tbk

PT Agung Podomoro Land (the company) was established under its original name of PT Tiara Metropolitan Jaya base on notarial deed No.29 of Mrs Sri Laksmi Damayanti, S.H, dated on 30 Jul, 2004. The Companys articles of association has been amended several times, most recently by notarial deed No. 79 of Yulia, S.H., dated Jun 25, 2010, concerning among others, the change in the Company’s name, Par value and public offering.

Read more on APLN

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK